Apollomics Stock (NASDAQ: APLM) stock price, news, charts, stock research, profile.
You can purchase shares of Apollomics (NASDAQ:APLM) through any online brokerage.
Other companies in Apollomics’s space includes: NKGen Biotech (NASDAQ:NKGN), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).
Apollomics has a consensus price target of $8.50.
The stock price for Apollomics (NASDAQ: APLM) is $0.132 last updated September 25, 2024 at 8:39 AM EDT.
There are no upcoming dividends for Apollomics.
Apollomics’s H1 earnings are confirmed for Wednesday, August 14, 2024.
There is no upcoming split for Apollomics.
Apollomics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.